O nas

1CryoBio AG bazując na duńskim projekcie i szwajcarskej jakości stworzyło unikalny produkt aby ulepszyć przechowywanie i pracę z materiałem biologicznym. 1CryoBio AG projektuje, produkuje i sprzedaje krioprobówki które można łamać aby usprawnić przechowywanie materiału biologicznego. Naszym pierwszym produktem jest FlexiQuot™. Jest to nowatorski system pozwalający wyjąć jasno zdefiniowany fragment zamrożonej próbki bez wpływu na pozostały materiał biologiczny. Aktualnie dostępnych jest pięć zdefiniowanych punktów łamania pozwalających na osiągnięcie 1 ml fragmentów zamrożonej próbki. FlexiQuot™ wkrótce będzie dostępny dla mniejszych objętości.


Bruno Ehrler, CEO, B.SC, B.ENG, LIC., MBA HSG

Before stepping into his role as the Chief Executive Officer of 1CryoBio AG, Mr. Ehrler practiced as an Industrial Engineer and Six Sigma Voice-of-the-Customer Champion in several industries. He has held full responsibility for multi-million dollar projects executed with international cross-functional teams. In addition, Mr. Ehrler brings experience of start-up businesses and has proven his leadership in various fields. He has completed studies and courses at a wide variety of universities and business schools globally.

Ove Anderson, CTO, Inventor and Board Member

Dr. Andersen holds an M.D., Ph.D. in Immunology, is a specialist in Internal Medicine and Infectious Diseases, and is Clinical Associate Professor at Copenhagen University. Dr. Andersen is also Head of the Clinical Research Centre at Copenhagen University Hospital, Amager Hvidovre. Dr. Andersen is co-author of more than 90 scientific publications and is inventor and co-inventor of four patents. Dr. Andersen has commercialization experience as founder of Profylakse Aps and Oracain Aps, were he was in charge of scientific and clinical studies, with responsibility for management and design of trials, product design and overall co-ordination of the development programs.

Dr. Jørgen Thorball, Chairman

Dr. Jørgen Thorball (52), Chairman, started his career in international corporate management positions in the pharmaceutical industry (Pharmacia and Aventis) where he had global product responsibility. As Managing Partner in XOventure GmbH he subsequently built more than 30 life science companies and led a series of merger and acquisition transactions, as well as business development innovations. In 2010, Jørgen Thorball was awarded the Medicon Valley Cross Border Award for his achievements.

Bruno Odermatt, CFO

Mr. Odermatt is the founder of and partner at Value Solutions Group. His previous experience includes serving as Head of Center of Competence Valuation and Member of the Managing Team for Corporate Finance/Corporate Recovery at KPMG and CFO at Prionics, as well as a number of board and management positions.

John Reddington, Ph.D., DVM

Dr. Reddington currently serves as COO of Cambridge Biomedical, MA (USA), and has started and managed several private and public biotech companies for almost 25 years. Most recently, he served as President and CEO of Sirtex Medical, where he reorganized and revitalized the U.S. division.

Edward C. Cappabianca, BA, MBA

Mr. Cappabianca is CEO of EnXray Limited and Managing Director at CapeWhite Consulting Ltd. His previous experience includes CEO of AmpliPhi Biosciences Corporation and over 20 years as an investment banker with leading firms, including Alex, Brown & Sons, William Blair & Co, and Rodman & Renshaw LLC.

Markus Billeter, MSC ETH, MBA HSG

Julian Lichtsteiner, BSC, MBA HSG

Mr. Lichtsteiner has a background in Psychology and obtained his Bachelor of Science degree from the University of Berne. He has lived, studied and worked in Switzerland and the U.S. His expertise is in sales and marketing.

Otto Skolling


Silny zespół globalny

1CryoBio AG projektuje swoje produkty w pełnej współpracy z Laboratorium Badawczym Szpitala Hvidovre - Dania, Uniwersytetem w Kopenhadze - Dania, XOventure - czołowymi ekspertami ze Skandynawii w dziedzinie LifeScience, Instytutem Karolinska - Szwecja, Cambridge Biomedical - USA, Kringlan Composities - Szwajcaria oraz z ciągłą wymianą wiedzy z czołowymi instytucjami w Europie i Ameryce. Z duńskim projektem i szwajcarską jakością, 1CryoBio AG ciągle rozwija partnerstwo w celu testowania swoich produktów w różnych dziedzinach zastosowań.